Bloodwork question about BPC-157. Baseline, eight months in, and the numbers moved in a direction I did not expect.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
The interesting question is not whether it works but for whom and at what cost.
If it needs three other compounds to notice, you have not tested the first one.
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
What is the first thing you would read if you were starting from zero?
Test one thing at a time. It feels slower and it is the only way to learn anything.
Most of what is called evidence here is one person, one vial, one month.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
Stupid question: how do you know whether what is in the vial matches the label at all?
Stupid question: how do you know whether what is in the vial matches the label at all?
What is the first thing you would read if you were starting from zero?
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.
Sleep, food, or the compound? Yes.
Where does the human data stop and the extrapolation begin? That is the whole thread.
Sleep, food, or the compound? Yes.
Same here.